|
Match
|
Document |
Document Title |
|
|
6783771 |
Physiologically active substance EEM-S originating in mushrooms, process for producing the same and drugs
EEM-S obtained by extracting with hot water or a lower alcohol at least one mushroom selected from among Lentinus edodes, Flammulina velutipes, Hypsizygus marmoreus, Pleurotus ostreatus, Pholiota...
|
|
|
6773722 |
Process for the preparation of granular and porous sucralfate dry gel
Sucralfate gel in the dry state in porous granular form having a particle-size distribution of between 100 and 1000 μm, an apparent density of the powder bed of between 0.7 and 0.9 g/ml, a...
|
|
|
6767567 |
Ingestible elements
The invention relates mainly to an element suitable for being ingested, the element including at least one air-passing channel making it possible to avoid choking in the event of being swallowed...
|
|
|
6764696 |
Effervescent drug delivery system for oral administration
The pharmaceutical compositions of the present invention comprise orally administerable dosage forms that use effervescence as a penetration enhancer for drugs known, or suspected, of having poor...
|
|
|
6764695 |
Tablet and process for producing tablets
A tablet including active substance affected by lubricant, wherein the tablet is comprised of compressed mixture of active substance and adjuvant except for lubricant, and lubricant exists only on...
|
|
|
6761907 |
Coated dosage units
Dosage units, such as tablet cores and granules, containing a composition comprising a steroid having two hydrogen atoms at position 3 of the steroid skeleton, are coated. While a conventional...
|
|
|
6753333 |
Chiral fluoroquinolone arginine salt forms
The invention relates to the new arginine salt forms of S-(−)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-m
ethyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid, a process for their...
|
|
|
6753012 |
Method for coating pharmaceutical dosage forms
The invention provides a process for coating a branded pharmaceutical dosage form for the purpose of covering any embossed or printed matter or any colored coating by the application of an amount...
|
|
|
6750249 |
Controlled release oral preparations of esculetin and its derivatives
The present invention relates to an oral preparation of esculetin with controlled release. The oral preparation of esculetin with controlled release of the present invention comprises a gel-forming...
|
|
|
6749867 |
Delivery system for omeprazole and its salts
The present invention provides a time-release dosage form for delivering an acid-labile pharmaceutical, such as omeprazole, into the upper portion of the gastrointestinal tract downstream of the...
|
|
|
6743445 |
Low temperature coatings
A method of coating an active material is provided. The method comprises contacting an active material with a film-forming composition comprising an aqueous dispersion of an amylose-alcohol...
|
|
|
6743443 |
Tablets immediately disintegrating in the oral cavity
The present invention provides an intraoral quickly disintegrating tablet containing a phosphodiesterase inhibitor having an effect of improving the erectile dysfunction and a method for...
|
|
|
6740340 |
Pharmaceutical tablets comprising an NSAID and a prostaglandin
A pharmaceutical tablet which incorporates two smaller tablets, one of which comprises an NSAID and the other of which comprises misoprostol.
|
|
|
6733784 |
Coated, platform-generating tablet
An expanding tablet is described comprising a drug release controlling membrane material. After swallowing, the tablet hydrates and expands such that the membrane ruptures to directly expose some...
|
|
|
6733780 |
Direct compression polymer tablet core
The present invention provides a tablet core which comprises at least about 95% by weight of an aliphatic amine polymer. The invention also provides a method of producing a tablet core comprising...
|
|
|
6730319 |
Pharmaceutical compositions having depressed melting points
The present invention relates to pharmaceutical compositions that contain a solid pharmaceutically active compound having a melting point ≧37° C. and a fatty acid or a fatty acid salt or a...
|
|
|
6730321 |
Press coated, pulsatile drug delivery system suitable for oral administration
A press-coated tablet suitable for oral administration, comprising an immediate-release compartment comprising a compressed blend of an active agent. The immediate-release compartment has a...
|
|
|
6726927 |
Preparation of enteric pharmaceutical dosage forms for omerprazole and lansoprazole
The present invention relates to new stable enteric coated pharmaceutical dosage forms for oral use containing Omeprazole or Lansoprazole, to a formulation and a method for the manufacture of such...
|
|
|
6726930 |
Sustained release heterodisperse hydrogel systems for insoluble drugs
A sustained release pharmaceutical formulation includes a sustained release excipient including a gelling agent, an inert pharmaceutical diluent, an optional cationic cross-linking agent, and a...
|
|
|
6723342 |
Edible coating composition
An edible, hardenable coating composition containing microcrystalline cellulose and carrageenan and at least one of a strengthening polymer, a plasticizer, a surface active agent or a combination...
|
|
|
6723737 |
Methods, pharmaceutical and therapeutic compostions for administering adenosine
The invention discloses methods for the chronic administration of adenosine, which contrary to the acute delivery of the drug by injection or infusion, acts in desensitizing adenosine receptors...
|
|
|
6713089 |
Quick release pharmaceutical compositions of drug substances
The present invention relates to an oral modified release pharmaceutical composition for the administration of a therapeutically and/or prophylactically effective amount of an active substance (a...
|
|
|
6709678 |
Easy to swallow oral medicament composition
An oral composition which is adapted to be dispersed in an aqueous carrier substantially immediately prior to administration comprises a multiplicity of particles comprising an active substance,...
|
|
|
6706284 |
Bitterness-reduced oral pharmaceutical composition
The invention relates to an oral pharmaceutical composition which has excellent drug release-controlling ability in the mouth even 5 to 10 minutes after its administration and also has excellent...
|
|
|
6706285 |
Enteric coated formulation of a benzimidazole derivative and method for preparation thereof
Disclosed are an enteric coated formulation of a benzimidazole derivative comprising a core and a film of an enteric coating agent on the surface thereof, the core containing a complex of the...
|
|
|
6699508 |
Sustained release oral preparations of fasudil hydrochloride
An oral sustained-release preparation which contains at least one active ingredient selected from the group consisting of fasudil hydrochloride and a hydrate thereof is disclosed. A method for...
|
|
|
6696085 |
Use of an acrylic type polymer as disintegrating agent
The present invention provides for the use of a polymer of the acrylic type as a disintegration agent.
|
|
|
6696083 |
Vitamin/nutrient dosage regimentation
The efficacy of vitamins and other nutritional agents in treating and preventing various disease states is improved by administering therapeutically effective levels of these agents on a...
|
|
|
6696087 |
Phosphate-binding polymer preparation technical field
A tablet containing a phosphate-binding polymer, which has an average particle size of 400 μm or less, contains particles of 500 μm or less in particle size at a ratio of 90% or more and has a...
|
|
|
6692768 |
Preparation method of drug-containing spherical fine particles
The present invention discloses an efficient preparation method of spherical fine particles containing a drug for an easily-swallowed, controlled-release preparation comprising the production of...
|
|
|
6682759 |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
A method is disclosed for manufacturing a pharmaceutical tablet for oral administration, the tablet combining both immediate-release and prolonged-release modes of drug delivery and using an...
|
|
|
6676966 |
Extended release metformin hydrochloride formulations
An extended release formulation of metformin hydrochloride is disclosed. The metformin hydrochloride is encased within polymeric film layers providing for gradual release of the metformin...
|
|
|
6673365 |
Formulation for treatment of thromboembolism
A new pharmaceutical formulation comprising the thrombin inhibitor HOOC—CH 2 —(R)-Cgl-Aze-Pab in combination with medium chain glycerides, a process for the preparation of such a pharmaceutical...
|
|
|
6670038 |
Method of depositing particles with an electrostatic chuck
The present invention is directed to electrostatic chucks, methods for their use, the electrostatic deposition of objects, such as particles in a dry powder, onto recipient substrates, and the...
|
|
|
6669956 |
Tablets incorporating isoflavone plant extracts and methods of manufacturing them
The invention is directed to novel tablets comprising isoflavone-containing plant extract and water-insoluble polysaccharides, and methods of manufacturing them.
|
|
|
6664267 |
Crystalline fluoroquinolone arginine salt form
The invention relates to the new arginine salt forms of RS-(±)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-m
ethyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid,...
|
|
|
6663893 |
Taste masking coating composition
There is provided a coating composition that masks the undesirable taste of a pharmaceutically active ingredient, i.e. drug or medicine, that is taken orally. The coating composition is comprised...
|
|
|
6656503 |
Pharmaceutical tablet comprising an NSAID and misoprostol
A pharmaceutical tablet comprising a core and a film coating wherein the core comprises an NSAID and the film coating comprises a polymer and misoprostol.
|
|
|
6649188 |
Highly flexible starch-based films
Film-forming compositions are disclosed that can comprise, on a dry solids basis, 25 to 75 percent by weight of certain starch derivatives and 25 to 75% primary external plasticizer. The starch...
|
|
|
6649187 |
Use of polyalkylamine polymers in controlled release devices
The invention provides a method and device for administering an amine drug, such as...
|
|
|
6645524 |
Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
Novel pharmaceutical dosage forms provide for pulsatile delivery of an antiarrhythmic agent that releases the drug in spaced apart “pulses.” The dosage forms are comprised of first, second and...
|
|
|
6642276 |
Controlled release macrolide pharmaceutical formulations
Disclosed is an oral controlled release macrolide pharmaceutical formulation. In a preferred embodiment, the formulation comprises a citrate salt of a preferred macrolide, clarithromycin. Also...
|
|
|
6641840 |
Sustained release formulations for growth hormone secretagogues
The present invention relates to formulations for administering a growth hormone secretagogue. More specifically, the present invention relates to sustained release formulations for administering a...
|
|
|
6638521 |
Oral liquid mucoadhesive compositions
The present invention relates to a per oral, oral, or intranasal pharmaceutical mucoretentive, aqueous liquid composition comprising from about 2% to about 50%, by weight of the composition, of...
|
|
|
6635279 |
Active ingredient-containing floating forms comprising polyvinyl acetate and polyvinylpyrrolidone, their use and production
The present invention relates to oral dosage forms comprising a) one or more active ingredients b) a formulated mixture of polyvinyl acetate and polyvinylpyrrolidone c) where appropriate other...
|
|
|
6635680 |
Controlled release pellet formulation
The present invention describes an aqueous pharmaceutical coating formulation which can be used for coating core elements containing one or more medicaments to achieve controlled release. The...
|
|
|
6635275 |
Modified starch film compositions
The invention concerns compositions from modified starches, such as starch ethers or oxidized starch, more particularly hydroxpropylated starch (HPS) or hydroxylethylated starch (HES) for the use...
|
|
|
6632451 |
Delayed total release two pulse gastrointestinal drug delivery system
A two pulse gastrointestinal delivery system is provided. The system comprises a desired agent in combination with a swellable core material, the core being surrounded by an inner coat of a...
|
|
|
6632454 |
Multilayer pharmaceutical product for release in the colon
The invention relates to the use of a multilayer pharmaceutical product that substantially comprises a) a core containing a pharmaceutically active substance, b) an inner coating consisting of a...
|
|
|
6630158 |
Dietary supplement composition and method for improving and maintaining healthy skin
A dietary supplement composition for promoting healthy skin comprised of lycopene and other carotenoids, selenium, chromium and biotin.
|